The one-size-fits-all approach to pain management should be a thing of the past. But we’re still not there yet.

Exercise and aching muscles are intrinsically linked. Committing to a long run, heavy gym session or challenging cycle will ...

Tris Pharma’s first-in-class oral dual-NMR agonist achieved its primary endpoint in the ALLEVIATE-2 study by demonstrating a ...

U.S. researchers said Wednesday they have reproduced the pain-relieving effects of cannabis with a synthesized compound that ...

Tris Pharma, Inc. (Tris), a commercial-stage biopharmaceutical company, today announced positive topline results from its ...

“There is an urgent need to develop non-addictive treatments for chronic pain," says Susruta Majumdar, Ph.D of Washington University School. Approximately 125 million opioid prescriptions were ...

Non-opioid pain therapies are entering an unprecedented era, marked by the landmark FDA approval of Vertex’s Journavx and a ...

The Boston-based company's new medication, called Journavx, is being placed on a tier that means it might be costlier than ...

Researchers have developed a compound that relieves pain in mice but doesn't affect the brain, thereby avoiding mind-altering side effects and abuse potential. The custom-designed molecule, derived ...

A multidisciplinary team of University of Cincinnati Cancer Center researchers is leading a new clinical trial aimed to ...

Positive data from a pair of acute pain studies convinced the company that its drug, which works differently than existing ...